Imad Shureiqi
- Molecular Biology top 5%
- Oncology top 2%
- Pharmacology top 0.5%
- Cancer Research top 2%
- Genetics top 5%
- Co-authors
- Scott M. LippmanXiangsheng ZuoSusan M. FischerJeffrey S. MorrisYuanqing WuPeiying YangRobert A. NewmanMicheline J. Moussalli
- Topics
- Inflammatory mediators and NSAID effects (26 papers)Colorectal Cancer Treatments and Studies (19 papers)Cancer, Lipids, and Metabolism (14 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Communications
- Partner nations
- United StatesChinaThailand
In The Last Decade
Imad Shureiqi
80 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Molecular Biology 1.7k
- Oncology 1.0k
- Pharmacology 970
- Cancer Research 914
- Genetics 467
Countries citing papers authored by Imad Shureiqi
This map shows the geographic impact of Imad Shureiqi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imad Shureiqi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imad Shureiqi more than expected).
Fields of papers citing papers by Imad Shureiqi
This network shows the impact of papers produced by Imad Shureiqi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imad Shureiqi. The network helps show where Imad Shureiqi may publish in the future.
Co-authorship network of co-authors of Imad Shureiqi
This figure shows the co-authorship network connecting the top 25 collaborators of Imad Shureiqi. A scholar is included among the top collaborators of Imad Shureiqi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imad Shureiqi. Imad Shureiqi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 45 | |
| 2 | 9 | |
| 3 | 27 | |
| 4 | 5 | |
| 5 | 8 | |
| 6 | 4 | |
| 7 | 45 | |
| 8 | 2 | |
| 9 | 18 | |
| 10 | 33 | |
| 11 | Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinomabreakdown → | 354 |
| 12 | 19 | |
| 13 | 35 | |
| 14 | 37 | |
| 15 | 46 | |
| 16 | 20 | |
| 17 | 98 | |
| 18 | 19 | |
| 19 | 49 | |
| 20 | 144 |
About Imad Shureiqi
Imad Shureiqi is a scholar working on Toxicology, Cancer Research and Pharmacology, having authored 80 papers that have together received 3.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (26 papers), Colorectal Cancer Treatments and Studies (19 papers) and Cancer, Lipids, and Metabolism (14 papers). The work is most often cited by research in Cancer Research (914 citations), Biochemistry (422 citations) and Pharmacology (970 citations). Imad Shureiqi has collaborated with scholars based in United States, China and Thailand. Frequent co-authors include Scott M. Lippman, Xiangsheng Zuo, Susan M. Fischer, Jeffrey S. Morris, Yuanqing Wu, Peiying Yang, Robert A. Newman, Micheline J. Moussalli, Dongning Chen and Reuben Lotan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.